Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. (Q42819570)
Jump to navigation
Jump to search
scientific article published on December 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. |
scientific article published on December 1998 |
Statements
Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer (English)
Markl ID
1 December 1998